Trisomy 21 News and Research

RSS
New ACMG guidelines recommend NIPT as optimal initial screening test for all pregnant women

New ACMG guidelines recommend NIPT as optimal initial screening test for all pregnant women

Clinical validation study on MaterniT GENOME test published in American Journal of Obstetrics and Gynecology

Clinical validation study on MaterniT GENOME test published in American Journal of Obstetrics and Gynecology

Researchers develop new growth charts for U.S. children with Down syndrome

Researchers develop new growth charts for U.S. children with Down syndrome

Study: Non-invasive prenatal testing works in women at high risk of having babies with Down's syndrome

Study: Non-invasive prenatal testing works in women at high risk of having babies with Down's syndrome

Non-invasive prenatal testing for Down's syndrome acceptable to parents

Non-invasive prenatal testing for Down's syndrome acceptable to parents

Non-invasive prenatal testing can detect maternal cancer at early stage

Non-invasive prenatal testing can detect maternal cancer at early stage

Panorama SNP-based non-invasive prenatal test can detect complete molar pregnancy

Panorama SNP-based non-invasive prenatal test can detect complete molar pregnancy

Natera, LifeLabs sign new agreement for non-invasive prenatal testing in Canada

Natera, LifeLabs sign new agreement for non-invasive prenatal testing in Canada

Findings of Ariosa's non-invasive prenatal testing study published online in NEJM

Findings of Ariosa's non-invasive prenatal testing study published online in NEJM

LifeCodexx announces promising results from proof-of-principle study of qPCR-based NIPT assay

LifeCodexx announces promising results from proof-of-principle study of qPCR-based NIPT assay

BGI study tracks accuracy of NIFTY prenatal test

BGI study tracks accuracy of NIFTY prenatal test

Cell-free fetal DNA testing more effective in detecting Down syndrome

Cell-free fetal DNA testing more effective in detecting Down syndrome

BGI issued patent for non-invasive prenatal genetic test technology

BGI issued patent for non-invasive prenatal genetic test technology

Decision-support guide for prenatal genetic testing, no cost for testing result in less prenatal test use

Decision-support guide for prenatal genetic testing, no cost for testing result in less prenatal test use

Sequenom's total revenues increase 62% to $39.8 million in Q2 2014

Sequenom's total revenues increase 62% to $39.8 million in Q2 2014

Computational biologists develop program for easy diagnosis of hereditary illnesses

Computational biologists develop program for easy diagnosis of hereditary illnesses

Study sheds light on how extra chromosome 21 upsets equilibrium of entire genome in Down syndrome

Study sheds light on how extra chromosome 21 upsets equilibrium of entire genome in Down syndrome

cfDNA testing lowers false positive rates and higher predictive values in general obstetric population

cfDNA testing lowers false positive rates and higher predictive values in general obstetric population

Natera initiates distribution partnership with ProPath for Panorama non-invasive prenatal screening test

Natera initiates distribution partnership with ProPath for Panorama non-invasive prenatal screening test

BGI Health to introduce NIFTY screening test to reduce miscarriages

BGI Health to introduce NIFTY screening test to reduce miscarriages